Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitorsIn: Communications Biology Jg. 4 (2021) Nr. 1, 276Online Volltext: dx.doi.org/ (Open Access)
-
A distinct oncogenerative multinucleated cancer cell serves as a source of stemness and tumor heterogeneityIn: Cancer Research Jg. 78 (2018) Nr. 9, S. 2318 - 2331Online Volltext: dx.doi.org/ (Open Access)
-
Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cellsIn: OncoTarget Jg. 8 (2017) Nr. 56, S. 95945 - 95964Online Volltext: dx.doi.org/ (Open Access)
-
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS) : a double-blind, randomised controlled trialIn: Lancet Jg. 387 (2016) Nr. 10021, S. 866 - 873Online Volltext: dx.doi.org/ (Open Access)
-
Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elementsIn: Journal of Experimental & Clinical Cancer Research Jg. 34 (2015) Nr. 1, 81Online Volltext: dx.doi.org/ (Open Access)
-
Atypical cell populations associated with acquired resistance to cytostatics and cancer stem cell features : the role of mitochondria in nuclear encapsulationIn: DNA and Cell Biology Jg. 33 (2014) Nr. 11, S. 749 - 774Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging dataIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 52 (2014) Nr. 8, S. 642 - 652Online Volltext: dx.doi.org/
-
Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells.In: International Journal of Clinical Pharmacology and Therapeutics Jg. 52 (2014) Nr. 9, S. 787 - 801Online Volltext: dx.doi.org/
-
A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With DocetaxelIn: Journal of Cardiovascular Pharmacology Jg. 61 (2013) Nr. 6, S. 495 - 504Online Volltext: dx.doi.org/
-
7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cellsIn: Phytomedicine: International Journal of Phytotherapy and Phytopharmacology Jg. 19 (2012) Nr. 14, S. 1298 - 1306Online Volltext: dx.doi.org/
-
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-nave patients with unresectable exocrine adenocarcinoma of the pancreas-a study within the Central European Society Anticancer Drug Research (CESAR) collaborative networkIn: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 2, S. 280 - 286Online Volltext: dx.doi.org/ (Open Access)
-
Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumorsIn: Cancer Chemotherapy and Pharmacology Jg. 69 (2012) Nr. 3, S. 753 - 761Online Volltext: dx.doi.org/
-
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44) : a randomised phase 3 trialIn: Lancet Oncology Jg. 13 (2012) Nr. 2, S. 135 - 144Online Volltext: dx.doi.org/
-
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancerIn: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 30 (2012) Nr. 3, S. 1138 - 1143Online Volltext: dx.doi.org/
-
Phase i open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumoursIn: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 30 (2012) Nr. 5, S. 1962 - 1971Online Volltext: dx.doi.org/
-
Regorafenib (BAY 73-4506) in advanced colorectal cancer : a phase I studyIn: British Journal of Cancer (BJC) Jg. 106 (2012) Nr. 11, S. 1722 - 1727Online Volltext: dx.doi.org/ (Open Access)
-
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 30 (2012) Nr. 3, S. 1184 - 1192Online Volltext: dx.doi.org/
-
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatmentIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 49 (2011) Nr. 1, S. 96 - 98Online Volltext: dx.doi.org/
-
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patientsIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 49 (2011) Nr. 1, S. 88 - 90
-
Phase I study of telatinib (BAY 57-9352) : analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancerIn: Vascular Cell Jg. 3 (2011) S. 16Online Volltext: dx.doi.org/
-
Antiretroviral activity of two polyisoprenylated acylphloroglucinols, 7-epi-nemorosone and plukenetione A, isolated from Caribbean propolisIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 48 (2010) Nr. 10, S. 670 - 677Online Volltext: dx.doi.org/
-
First-line treatment of patients with metastatic pancreatic cancer : Results of a Phase II trial with S-1 (CESAR-Study group)In: International Journal of Clinical Pharmacology and Therapeutics Jg. 48 (2010) Nr. 7, S. 470 - 472Online Volltext: dx.doi.org/
-
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancerIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 48 (2010) Nr. 7, S. 473 - 475Online Volltext: dx.doi.org/
-
Lack of neuroprotection by an ACTH (4-9) analogue : A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphomaIn: Journal of Cancer Research and Clinical Oncology Jg. 130 (2004) Nr. 3, S. 153 - 160Online Volltext: dx.doi.org/
-
The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated Chronic Lymphocytic LeukemiaIn: Blood Jg. 142 (2023) Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 4639 - 4639Online Volltext: dx.doi.org/ (Open Access)